Decorative arrowsHMSA Provider Resource Center
HomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST Integration
Frequently Asked QuestionsUseful Web SitesContacting HMSA

Diagnostic Workup of Chronic Prostatitis - EXPIRED

Year Introduced:

Program year 2001


Focus of Measure:

To ensure that all eligible members, who are newly diagnosed with chronic prostatitis receive the appropriate follow-up tests within a clinical appropriate timeframe


Specialty Application:



Clinical Rationale:

Disease burden


Reason for indicated intervention or treatment


Evidence supporting intervention or treatment


Clinical recommendations



The medians for HMSA in 2007 were as follows:


Measurement Year:

January 1, 2006 - December 31, 2006



Continuously enrolled males with one diagnosis of chronic prostatitis in the inpatient setting or two diagnoses of chronic prostatitis in the outpatient setting during the period from one month after the beginning of the measurement year through two months prior to the end of the measurement year (i.e., nine months total)


Denominator Exclusions:

Males who were diagnosed with chronic prostatitis within one year (365 days) prior to the index diagnosis of chronic prostatitis



Males who had a either a microscopic urinalysis, urine culture, or evidence of evaluation of prostate-specific specimens, from one month prior through two months after the index diagnosis of chronic prostatitis


Interpretation of Score:

High score implies better performance


Indicator Classification:

Adapted from Health Plan Employer Data Information Set (HEDIS) technical specifications


Effectiveness of Care:

This measure is classified as a disease management measure. Disease management measures are those that are applicable to individuals who have been diagnosed with a condition and that are part of the treatment or management of the condition (e.g., cholesterol reduction in patients with diabetes; radiation therapy following breast conserving surgery; appropriate follow-up after an acute event).


Strength of Recommendation:


See Strength of Recommendation Based on a Body of Evidence - EXPIRED for the algorithm used to determine the strength of a recommendation. While this algorithm provides a general guideline, authors and editors of the PQSR clinical measures may adjust the strength of recommendation based on the benefits, harms and costs of the intervention being recommended.


The abbreviation USPSTF shown in the algorithm stands for United States Preventive Services Task Force.



  1. Collins MM, et al. How common is prostatitis? A national survey of physician visits. J Urol, 1998. 159(4): p. 1224-8.
  2. Mehik A, et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int, 2000. 86(4): p. 443-8.
  3. Stamey T. Urinary tract infections in males., in Pathogenesis and treatment of urinary tract infections., T. Stamey, Editor. 1980, Williams and Wilkins: Baltimore. p. 342-429.
  4. Calhoun EA, et al. The economic impact of chronic prostatitis. Arch Intern Med, 2004. 164(11): p. 1231-6.
  5. Nickel JC, LM Nyberg and M Hennenfent. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology, 1999. 54(2): p. 229-33.
  6. Dennis L Kasper, EB Anthony Fauci, Stephen Hauser, Dan Longo, J Larry Jameson. Harrison's Principles of Internal Medicine. 16th.
  7. McNaughton Collins M, R MacDonald and TJ Wilt. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med, 2000. 133(5): p. 367-81.
  8. Meares EM and TA Stamey. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol, 1968. 5(5): p. 492-518.
  9. Roberts RO, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology, 1998. 51(4): p. 578-84.
  10. Moon TD. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis. Urology, 1997. 50(4): p. 543-7.
  11. McNaughton Collins M, et al. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test?  Urology, 2000. 55(3): p. 403-7.
  12. Nickel JC. The Pre and Post Massage Test (PPMT): a simple screen for prostatitis. Tech Urol, 1997. 3(1): p. 38-43.
  13. Seiler D, et al. [Four-glass or two glass test for chronic prostatitis]. Urologe A, 2003. 42(2): p. 238-42.
  14. Nickel JC, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol, 2003. 170(3): p. 818-22.
  15. Schaeffer AJ, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol, 2002. 168(3): p. 1048-53.
  16. Nickel J. Special report on prostatitis: state of the art. Rev Urol, 2001. 3: p. 94-98.
  17. Nickel JC. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology, 2002. 60(6 Suppl): p. 20-2; discussion 22-3.
  18. Nickel J. Clinical evaluation of the patient presenting with prostatitis. Eur Urol, 2003. 68 (Suppl): p. 1-4.


© 2007 Health Benchmarks and HMSA. All rights reserved.


Files that are in PDF format can be viewed using the free Adobe Reader or another PDF-reader application.

Decorative arrowsHomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST IntegrationFrequently Asked QuestionsUseful Web SitesContacting HMSA

Non-discrimination notice

Need a language interpreter?

ʻŌlelo Hawaiʻi | Bisaya | 繁體中文 | Ilokano | 日本語 | 한국어 | ພາສາລາວ | Kajin Ṃajōḷ | Lokaiahn Pohnpei | Gagana Sāmoa | Español | Tagalog | Tonga | Foosun Chuuk | Tiếng Việt